Lazard Asset Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.5M | Buy |
|
|||||
|
2025
Q1 | $3.11M | Sell |
|
|||||
|
2024
Q4 | $7.89M | Buy |
|
|||||
|
2024
Q3 | $11M | Buy |
|
|||||
|
2024
Q2 | $8.24M | Buy |
|
|||||
|
2024
Q1 | $3.17M | Buy |
|
|||||
|
2023
Q4 | $37K | Buy |
|
|||||
|
2023
Q3 | $37K | Buy |
|
|||||
|
2023
Q2 | $44K | Sell |
|
|||||
|
2023
Q1 | $130K | Buy |
|
|||||
|
2022
Q4 | $47K | Buy |
|
|||||
|
2022
Q3 | $1K | Sell |
|
|||||
|
2022
Q2 | $2K | Hold |
|
|||||
|
2022
Q1 | $3K | Sell |
|
|||||
|
2021
Q4 | $13K | Sell |
|
|||||
|
2021
Q3 | $17.3M | Sell |
|
|||||
|
2021
Q2 | $71.7M | Sell |
|
|||||
|
2021
Q1 | $120M | Sell |
|
|||||
|
2020
Q4 | $95.8M | Buy |
|